Related Experiment Video
Updated: Sep 27, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Lobar Cerebral Microbleeds Are Associated With Cognitive Decline in Patients With Type 2 Diabetes Mellitus
Pengfei Shao1,2,3, Hengheng Xu1,2,3, Xiaoning Sheng1,2,3
1Department of Neurology, Affiliated Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
Purpose:
Combined the number, volume, and location of cerebral microbleeds (CMBs), this study aimed to explore the different features of CMBs and their correlation with cognitive ability in patients with type 2 diabetes mellitus (T2DM).
Methods:
This study recruited 95 patients with T2DM and 80 healthy control (HC) individuals. AccuBrain®, an automated tool, was used to obtain the number and volume of CMBs. The scores on global cognition and five cognitive domains were derived from a battery of cognitive tests. The logistic regression and multivariate linear regression were conducted to determine the relationship between the CMBs (number, volume, and location) and cognitive ability in patients with T2DM.
Results:
After adjusting for several variables, the total volume of CMBs (OR = 0.332, 95%CI: 0.133-0.825, and p = 0.018) was independent risk factor for cognitive impairment, whereas the total number of CMBs was not (OR = 0933, 95%CI: 0.794-1.097, and p = 0.400). Furthermore, the volume of CMBs in lobar regions was independently associated with working memory (β = -0.239, 95%CI: -0.565 to -0.035, and p = 0.027). However, no significant correlation between the number of CMBs (both lobar and deep/infratentorium) and any cognitive domains was observed.
Conclusions:
Lobar CMBs was related with cognitive impairment in patients with T2DM and might be a potential early warning signal. Compared with the counting analysis, the quantitative method offered a more sensitive and objective measurement for studying imaging features of CMBs.
Insights
The total volume of cerebral microbleeds (CMBs) is a risk factor for cognitive impairment in type 2 diabetes mellitus (T2DM) patients. Lobar CMB volume specifically impacts working memory, suggesting CMBs as potential early warning signs.
Area of Science:
- Neurology
- Radiology
- Endocrinology
Background:
- Type 2 diabetes mellitus (T2DM) is associated with an increased risk of cognitive decline.
- Cerebral microbleeds (CMBs) are small lesions in the brain that can be detected using neuroimaging.
- The relationship between CMBs and cognitive function in T2DM patients requires further investigation.
Purpose of the Study:
- To explore the distinct features of cerebral microbleeds (CMBs), including number, volume, and location.
- To investigate the correlation between CMBs and cognitive ability in patients with type 2 diabetes mellitus (T2DM).
Main Methods:
- Recruited 95 T2DM patients and 80 healthy controls (HC).
- Utilized AccuBrain®, an automated tool, for CMB quantification (number and volume).
- Assessed global cognition and five cognitive domains using a cognitive test battery.
- Employed logistic and multivariate linear regression to analyze CMBs-cognition relationships.
Main Results:
- Total CMB volume, but not number, was an independent risk factor for cognitive impairment in T2DM patients (OR = 0.332, p = 0.018).
- Lobar CMB volume was significantly associated with impaired working memory (β = -0.239, p = 0.027).
- No significant correlation was found between the number of CMBs (lobar or deep/infratentorial) and any cognitive domains.
Conclusions:
- Lobar CMBs are linked to cognitive impairment in T2DM patients and may serve as an early warning sign.
- Quantitative analysis of CMBs provides a more sensitive and objective measurement compared to simple counting.
- These findings highlight the importance of CMB volume and location in understanding cognitive deficits in T2DM.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Diabetes: Symptoms, Diagnosis, and Complications
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetes Mellitus: Type 2 and Gestational

